Some pharmacies have attempted to create compounded oral tirzepatide versions, yet these are not endorsed by the FDA
doi: 10.2337/diacare.28.12.2948 Summary Keywords type 2 diabetes, tirzepatide, counterregulatory response, hypoglycemia, clinical trial Citation Pieber TR, Svehlikova E, Urva S, Haupt A, Zhou C, Coskun T, Hller V, Fluhr G, Karanikas CA, Milicevic Z and Pratt EJ (2025) Counterregulatory response to hypoglycemia during a hypoglycemic clamp in people with type 2 diabetes treated with tirzepatide
Magnesium citrate or magnesium glycinate pull water into the intestines, which softens things up
According to the FDAs Drug Safety Communications, the agency continues to evaluate whether GLP-1 receptor agonists are associated with depression or suicidal ideation
Because the drugs work in different ways, Ozempic won't replace metformin entirely
Among the side effects of SGLT2 inhibitors, euglycemic diabetic ketoacidosis (EDKA) is one of the most concerning and potentially life-threatening complications